A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes

Journal of Clinical Oncology

Volumn 4, Issue 12, 1986, Pages 1857-1864

  Cheson, B D ^a   Jasperse, D M ^a   Simon, R ^a   Friedman, M A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE;

ACUTE LEUKEMIA; ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW DEPRESSION; CANCER CHEMOTHERAPY; CYTOGENETICS; DRUG DOSE; DRUG EFFICACY; DRUG THERAPY; DRUG TOXICITY; HEREDITY; HUMAN; INTOXICATION; LEUKEMIA REMISSION; MYELODYSPLASTIC SYNDROME; NONLYMPHATIC LEUKEMIA; PRIORITY JOURNAL; REVIEW; SECOND CANCER; THERAPY;

EID: 0022873032     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1986.4.12.1857     Document Type: Review

References (0)